Results 211 to 220 of about 121,778 (347)
Abstract Kinase inhibitors are essential in targeted cancer therapy, yet resistance often emerges through secondary mutations, activation of compensatory signaling pathways, or drug‐efflux mechanisms. Artificial intelligence (AI) provides a workflow‐based strategy rather than a list of unrelated tools for predicting and addressing kinase‐inhibitor ...
Faris Hassan +3 more
wiley +1 more source
A diverse semisynthetic humanized scFv phage display library for anti-CXCL16 antibodies. [PDF]
Li Z, Chen Q, Wang S, Chen J, Chen S.
europepmc +1 more source
Tumor Cell Migration May Be an Inherent “Foraging” Behavior
Tumor cells gradually form pseudopodia, migrate to necrotic cells, make contact with them, and absorb necrotic cell debris. During this migration, small vesicles formed by dying tumor cells also gradually migrate toward living tumor cells. Once the nutrients from the necrotic cells have been completely absorbed, the living tumor cells will leave ...
Fuqian Zhao +4 more
wiley +1 more source
Chemokine-Binding All-D-CLIPS Peptides Identified Using Mirror-Image Phage Display. [PDF]
Denisov SS +11 more
europepmc +1 more source
Covalent Peptide Evolution: Redefining Protein–Protein Interaction Inhibition Through Phage Display [PDF]
Nelson Santiago Vispo
openalex +1 more source
Principles and Practice Guidelines of Microbiota Medicine: Statements From the CHINAGUT Conference
The 2025 CHINAGUT Conference convened a panel of 48 clinicians from 39 hospitals in 5 countries to develop 15 key statements, aimed at providing clinicians, educators, and healthcare administrators with a comprehensive framework to advance education, clinical practice, research, and public popularization in microbiota medicine.
Faming Zhang +52 more
wiley +1 more source
Phage display enables machine learning discovery of cancer antigen-specific TCRs. [PDF]
Croce G +19 more
europepmc +1 more source
Washed microbiota transplantation using ileocolic transendoscopic enteral tubing was identified as a viable, effective and safe bridge treatment for intestinal inflammatory obstruction in Crohn's disease, demonstrating significantly higher 28‐day improvement rates compared to basic treatment.
You Yu +11 more
wiley +1 more source

